Arthritis drugs move to self-administered list; watch for denial increase
If you’re seeing denials for three commonly used injectable drugs to treat arthritis, a little-noticed policy change from your Medicare Administrative Contractor (MAC) may be to blame. An increasing number of MACs have moved the drugs to the list of those usually self-administered by the patient, making them ineligible for reimbursements under Part B.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.